巨子生物 02367·

毛利率 83.28%--84.59%1.32%87.24%2.64%84.39%2.85%83.63%0.76%82.09%1.54%80.34%1.76% 净利率 60.12%--69.42%9.30%53.34%16.08%42.36%10.98%41.09%1.27%37.22%3.87%34.70%2.53% ROE 48.12%--180.45%132.33%81.44%99.00%35.36%46.08%33.28%2.08%29.01%4.27%19.32%9.69% ROA --------10.51%--31.92%21.40%29.12%2.79%25.65%3.47%17.66%7.99% 营业收入增长率 ----24.44%--30.41%5.97%52.30%21.89%49.05%3.25%57.17%8.12%-0.37%57.53% 归属母公司净利润增长率 ----49.65%--0.20%49.45%21.00%20.79%44.88%23.88%42.06%2.82%-7.15%49.21% 资产负债率 --------87.09%--9.60%77.50%12.11%2.51%11.42%0.68%8.45%2.97% 流动比率 2.33--1.051.281.090.049.037.957.791.247.660.1411.273.62 经营现金流 / 净利润 1.14--1.010.130.840.170.930.091.140.210.990.150.930.06 经营现金流 / 营业收入 68.62%--70.07%1.45%44.60%25.47%39.40%5.20%46.75%7.35%36.85%9.89%32.27%4.59%

毛利率 81.68%--79.46%2.22% 净利率 37.99%--32.20%5.79% 营业收入增长率 -----6.26%-- 归属母公司净利润增长率 -----20.50%-- 资产负债率 ----9.40%-- 流动比率 ----10.63--

营业收入 9.57 亿--11.90 亿24.44%15.52 亿30.41%23.64 亿52.30%35.24 亿49.05%55.39 亿57.17%55.19 亿0.37% 其他收入及收益 3,116.60 万--2,138.60 万31.38%3,315.50 万55.03%6,871.20 万107.24%1.03 亿49.85%1.39 亿34.75%1.90 亿36.85% 营业成本 1.60 亿--1.83 亿14.64%1.98 亿8.04%---------------- 毛利 7.97 亿--10.07 亿26.40%13.54 亿34.48%19.95 亿47.32%29.47 亿47.71%45.47 亿54.28%44.33 亿2.50% 销售及分销费用 9,378.80 万--1.58 亿68.91%3.46 亿118.54%7.06 亿104.03%11.64 亿64.86%20.08 亿72.46%20.56 亿2.37% 行政费用 2,884.50 万--3,299.20 万14.38%7,227.40 万119.07%1.11 亿53.68%9,666.10 万12.98%1.51 亿55.74%1.68 亿11.91% 财务成本净额 ------------2.10 万--11.20 万433.33%23.90 万113.39%30.20 万26.36% 所得税 1.02 亿--1.47 亿44.14%1.45 亿1.34%1.76 亿21.67%2.97 亿68.53%3.96 亿33.39%4.36 亿10.00% 经营利润 --------9.73 亿--11.78 亿21.06%17.45 亿48.18%24.62 亿41.05%23.41 亿4.89% 除税前利润 6.77 亿--9.73 亿43.76%9.73 亿0.03%11.78 亿21.05%17.45 亿48.17%24.58 亿40.84%23.50 亿4.37% 净利润 5.75 亿--8.26 亿43.69%8.28 亿0.20%10.02 亿20.95%14.48 亿44.59%20.62 亿42.36%19.15 亿7.13% 归属母公司净利润 5.52 亿--8.26 亿49.65%8.28 亿0.20%10.02 亿21.00%14.52 亿44.88%20.62 亿42.06%19.15 亿7.15%

营业收入 31.13 亿--29.18 亿6.26% 其他收入及收益 6,880.00 万--1.42 亿106.57% 营业成本 5.70 亿--5.99 亿5.08% 毛利 25.42 亿--23.18 亿8.81% 销售及分销费用 10.59 亿--12.67 亿19.67% 行政费用 8,263.50 万--7,990.80 万3.30% 财务成本净额 12.40 万--17.50 万41.13% 所得税 2.62 亿--1.55 亿40.61% 经营利润 14.45 亿--10.85 亿24.90% 应占联营及合营公司损益 -91.40 万--982.80 万1175.27% 除税前利润 14.44 亿--10.95 亿24.18% 净利润 11.82 亿--9.40 亿20.54% 归属母公司净利润 11.82 亿--9.40 亿20.50%

现金及现金等价物 7,232.30 万--3.68 亿408.56%71.03 亿1831.19%13.31 亿81.26%25.04 亿88.14%40.30 亿60.95%63.06 亿56.47% 应收账款及票据 1,726.00 万--5,452.30 万215.89%6,563.90 万20.39%6,942.00 万5.76%1.02 亿46.97%1.41 亿38.47%2.02 亿42.88% 存货 5,086.30 万--6,465.60 万27.12%8,939.40 万38.26%1.84 亿105.71%2.00 亿9.00%3.11 亿55.07%3.91 亿25.82% 流动资产合计 14.58 亿--22.84 亿56.63%74.41 亿225.79%25.38 亿65.90%41.35 亿62.94%64.02 亿54.82%90.19 亿40.87% 总资产 --------78.78 亿--31.38 亿60.17%49.73 亿58.47%80.38 亿61.63%108.41 亿34.88% 流动负债合计 6.26 亿--21.74 亿247.24%68.43 亿214.78%2.81 亿95.90%5.31 亿88.89%8.36 亿57.55%8.00 亿4.31% 总负债 --------68.61 亿--3.01 亿95.61%6.02 亿99.88%9.18 亿52.51%9.17 亿0.16% 归属母公司股东权益 11.48 亿--4.58 亿60.09%10.17 亿122.01%28.33 亿178.66%43.62 亿53.95%71.08 亿62.95%99.11 亿39.44% 股东权益合计 11.51 亿--4.58 亿60.22%10.17 亿122.01%28.37 亿179.01%43.71 亿54.07%71.20 亿62.89%99.25 亿39.40%

现金及现金等价物 ----48.53 亿-- 应收账款及票据 ----3.89 亿-- 存货 ----3.54 亿-- 流动资产合计 ----83.12 亿-- 总资产 ----103.43 亿-- 流动负债合计 ----7.82 亿-- 总负债 ----9.72 亿-- 归属母公司股东权益 ----93.58 亿-- 股东权益合计 ----93.71 亿--

经营活动现金流量净额 6.56 亿--8.34 亿27.06%6.92 亿16.99%9.32 亿34.55%16.47 亿76.83%20.41 亿23.90%17.81 亿12.77% 投资活动现金流量净额 -5.90 亿---5.21 亿11.65%15.63 亿399.98%-8.59 亿154.93%-5.27 亿38.60%-11.06 亿109.78%-3.19 亿71.18% 融资活动现金流量净额 -216.40 万---1,752.30 万709.75%44.76 亿25640.97%-57.90 亿229.36%5,180.80 万100.89%5.83 亿1025.21%9.18 亿57.47% 现金及现金等价物净增加额 6,444.70 万--2.95 亿358.49%67.31 亿2178.04%-57.17 亿184.93%11.72 亿120.50%15.18 亿29.53%23.80 亿56.77%